openPR Logo
Press release

Exocrine Pancreatic Insfficiency Market to 2027 | Global Analysis and Forecasts By Key Players - ThermoFisher Scientific Inc.,ScheBo Biotech AG, Hologic Inc., Immunostics.

12-04-2018 05:50 AM CET | Health & Medicine

Press release from: The Insight Partners

Exocrine Pancreatic Insfficiency Market to 2027 - Global Analysis and Forecasts By Type

Exocrine Pancreatic Insfficiency Market to 2027 - Global Analysis and Forecasts By Type

Exocrine Pancreatic Insfficiency Market to 2027 - Global Analysis and Forecasts By Type (Imaging and Sample Test), End User (Hospitals, Diagnostic Laboratories and Others) and Geography. Exocrine pancreatic insufficiency (EPI) is characterized as deficiency in exocrine pancreatic enzymes that result into an inability to maintain normal digestion. EPI may be caused due to cystic fibrosis (CF) or chronic pancreatitis. The symptoms for this are weight loss, greasy and foul-smelling stools, stomach cramps, and diarrhea. The disorder is diagnosed with the help of blood test, fecal test or by the mode of imaging.

The exocrine pancreatic insufficiency market is likely to anticipate grow with a significant rate in the forecast years, owing to driving factors such as, rise in the prevalence of gastrointestinal disorders, ulcerative colitis, and small intestinal bacterial growth among others. In addition, increasing prevalence of the cystic fibrosis, pancreatic cancer, diabetes are likely to grow the market in the forecast years. The market is likely to seek various opportunities to develop easy test and innovative products to treat the exocrine pancreatic insufficiency.

Get Sample PDF Copy @ http://bit.ly/2PieyIZ

The "Global Exocrine Pancreatic Insufficiency Market Analysis To 2027" is a specialized and in-depth study of the medical device industry with a focus on the exocrine pancreatic insufficiency market trend. The report aims to provide an overview of global exocrine pancreatic insufficiency market with detailed market segmentation by type, end user and geography. The global exocrine pancreatic insufficiency market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the exocrine pancreatic insufficiency market.

Profiles of key exocrine pancreatic insufficiency market

1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Canon Medical Systems, USA
6. ThermoFisher Scientific Inc.
7. ScheBo Biotech AG
8. Hologic Inc.
9. Immunostics, Inc.
10. Biohit Oyj

The global exocrine pancreatic insufficiency market is segmented on the basis of type and end user. On the basis type segment includes imaging and sample test. The imaging segment is further divided into sub-segments such as CT scanning, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and others. Similarly, the sample test is further divided into blood test, fecal test and pancreatic function test. On the basis of the end user the segment is classified as hospitals, diagnostic laboratories and others.

North America is expected to contribute to the largest share in the exocrine pancreatic insufficiency market in the coming years, owing to factors such as, rise in the incidences of the bacterial infection, rise in the prevalence of the exocrine pancreatic insufficiency and more. The Europe and Asia Pacific market is anticipated to hold large market share following the North America. The rise in the geriatric population across these regions are likely to contribute to the significant growth rate for the market.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

Buy Complete Report @ http://bit.ly/2KSkOqe

The report also includes the profiles of key exocrine pancreatic insufficiency market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exocrine Pancreatic Insfficiency Market to 2027 | Global Analysis and Forecasts By Key Players - ThermoFisher Scientific Inc.,ScheBo Biotech AG, Hologic Inc., Immunostics. here

News-ID: 1414685 • Views:

More Releases from The Insight Partners

Future of Clean Energy - Complete Guide (PDF)
Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus on Opportunities, Development Strategy, Future Plans, Competitive Landscape and Trends by Forecast to 2031
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape and Industry Poised for Rapid Growth in Future 2031
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and
Nutraceuticals - An Ultimate PDF Guide
Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional

All 5 Releases


More Releases for Exocrine

Increasing Prevalence Of Chronic Diseases Boosts Growth Prospects For The Exocri …
The Exocrine Pancreatic Insufficiency Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Exocrine Pancreatic Insufficiency Market? In recent times, the market size for exocrine pancreatic insufficiency has experienced robust growth. Expected to rise from $2.59 billion in 2024 to
Prominent Exocrine Pancreatic Insufficiency Market Trend for 2025: Exocrine Panc …
What Are the Projected Growth and Market Size Trends for the Exocrine Pancreatic Insufficiency Market? The exocrine pancreatic insufficiency market has seen strong growth in recent years. It is projected to increase from $2.59 billion in 2024 to $2.76 billion in 2025, at a compound annual growth rate (CAGR) of 6.6%. The growth is driven by factors such as increased awareness and diagnosis, the rising prevalence of digestive disorders, an aging
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Exocrine Pancreatic Insufficiency Market - Positive long-term growth outlook 202 …
Exocrine pancreatic insufficiency (EPI) is a condition characterized by deficiency of exocrine pancreatic enzymes, resulting in the inability to digest food properly, a condition called maldigestion. These enzymes consist of lipases for fat digestion, proteases for protein digestion, and amylases for starch digestion. EPI results from various diseases such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, cytomegalovirus infection, and HIV/AIDS. The symptoms of EPI are maldigestion or malabsorption and specifically
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,
Exocrine Pancreatic Insufficiency Market Research and Forecast Report 2023
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 - 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market - (Therapeutic - Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,